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Biodegradable and thermoresponsive micelles of 
A
btriblock copolymers based on 2-(N,N-
dimethylamino)ethyl methacrylate and
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mphiphilic triblock copolymers, poly(2-(N,N-dimethylamino)ethyl methacrylate)x-block-poly(caprolactone)-
lock-poly(2-(N,N-dimethylamino)ethyl methacrylate)x, PDMAEMACo, were synthesized. Polymerization and 
structural features of the polymers were analyzed by different physicochemical techniques (GPC, 1H NMR 
and FTIR). Formation of hydrophobic domains as cores of the micelles was studied by 1H NMR and further 
conﬁrmed by ﬂuores-cence. Dynamic light scattering measurements showed a monodispersed size 
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Amphiphilic block copolymers contain hydrophobic
blocks covalently linked to hydrophilic blocks [1]. The
repulsion between the dissimilar groups leads to micro-
phase segregation into different domains. The chemical
connectivity between blocks and minimization of interfa-
cial energy deﬁnes the limits of these domains which are
on the nanoscopic scale. In solution the interaction be-
tween polymer and solvent adds an extra dimension to
the phase separation behaviour, especially when the sol-
vent is selective: a poor solvent for at least one of the
blocks and a good solvent for the others. Analogous ton Miguel), D.M.Had
@ictp.csic.es (F. Cata smaller surfactant molecules, amphiphilic block copoly-
mers self-assemble in an aqueous milieu in order to mini-
mize contact between hydrophobic segments and water.
Self-assembly begins when the copolymer concentration
reaches a threshold value known as the critical micelle
concentration (cmc). The morphology of the resulting
microstructure depends heavily on molecular architecture
[2] and micelles are the most common morphology.
Recently, polymer micelles have received increasing
attention, not only due to their unique morphological
behaviour, but also for their potential in drug delivery [3–
6]. The goal of chemotherapy is to deliver an anticancer
agent, typically a small molecule, at a high dose to a tumor
to kill rapidly proliferating tumor cells. Unfortunately, the
maximumdose ofmany chemotherapeutic agents is limited
by their high levels of systemic toxicity in normal tissues, so
that the administered dose is frequently suboptimal for
effective therapy. Consequently, a number of approaches1
havebeen investigated todecrease the systemic toxicity and
increase the therapeutic index of anticancer drug bydirectly
targeting the tumor with macromolecular drug carriers. In
particular biodegradable amphiphilic block copolymers for
polymeric delivery devices serve as unique materials to
overcome some of these problems. Owing to their small size
and excellent biocompatibility, nanosizedpolymers bearing
therapeutic agents can circulate in the bloodstream for pro-
longedperiodsof time, allowing themtoreach the target site
and improving the therapeutic efﬁciency of drugs. In addi-
tion, micelles in aqueous solutions are formed by a hydro-
phobic core, which may serve as container for poorly
water-soluble drugs. The corona micelle determines inter-
actions with the external environment which depends on
the chemical and physical nature of the hydrophilic block.
Another key issue in anticancer drug delivery is the tar-
geting strategy. It has been demonstrated that polymeric
micelles based drug nanocarriers can preferentially and
effectively accumulate in solid tumors. This phenomenon
is explained by the microvascular hyperpermeability to cir-
culating macromolecules and their impaired lymphatic
drainage in solid tumors, and is termed the ‘‘Enhanced Per-
meability and Retention (EPR) effect”. Active tumor target-
ing may be achieved by stimuli-responsive micelles that
release their drug load in response to environmental or
physical stimuli, such as the lower of pH in the tumor tissue,
heat sound or light. For example, thermosensitive drug car-
rier undergoes a structural transition as a response of tem-
perature increase, resulting in the deposition of the drug
and easier drug absorption by cells. Most of the thermosen-
sitive micelles are known to aggregate below physiological
temperature (37 C) and therefore, they deposit as soon as
they are injected in the body.A good choice is to usemicelles
with a LCST (lower critical solution temperature) above the
temperature of clinical hyperthermia (above 40 C). This
type of the thermoresponsive micelles can release a drug
on demand in response to a local tumor heating to the LCST
by, for example, continuous wave ultrasound.
Hydrophilic blocks commonly used in drug delivery in-
clude polyethers such as poly(propylene oxide) and PEG
[7,8]. Other hydrophilic polymers may be used such as
poly(2-( N,N-dimethylamino)ethyl methacrylate) (PDMA-
EMA) due to its biocompatibility, pH sensitivity [9–11]
and thermoresponsiveness [12–14]. Recently, well-deﬁned
dendritic star-block-poly(L-lactide)b-poly(2-(N, N-dimeth-
ylamino)ethyl methacrylate) copolymers have been pre-
pared [15]. These systems have been proved useful as
drug release vehicles and the release rate of an anticancer
drug was effectively controlled by altering the pH of the
medium. In spite of the potential cytotoxicity, water-solu-
ble polycations have been described for various technical
and biomedical applications [16].
Nanocarriers used for drug delivery need to be biode-
gradable, biocompatible, non-immunogenic and physically
stable in blood stream. Poly(e-caprolactone), PCL, is an ali-
phatic polyester of interest for biomedical applications ow-
ing to its good compatibility, low immunogenicity and FDA
approval. For drug release applications, the advantages of
PCL include its favourable permeability to drugs and less
acidic degradation products as compared to polylactide
and polyglycolide [17]. PCL is a biodegradable polymerand can undergo hydrolytic degradation. However, PCL
has suffered from the lack of controlled degradation due
to its crystallinity and hydrophobicity. Introduction of
hydrophilic units have used to improve biodegradability
and hydrophilicity.
A considerable effort has been carried out in the last
decade to relate the structure and micellar characteristics
to the drug loading and release behaviour from block
copolymers. In this study, we explore the potential of the
novel micelles as a drug delivery vehicle for lipophilic
drugs and analyze the effects that the chemical structures
of the shell-forming hydrophilic block have on drug incor-
poration. For this purpose, we synthesized three different
triblock copolymers poly(dimethylaminoethyl methacry-
late)x-block-poly(caprolactone)-block-poly(dimethylami-
noethyl methacrylate)x by ATRP (atom transfer radical
polymerization) using a difunctional macroinitiator based
on poly(caprolactone). And the micellization behaviour
has been studied by 1H NMR, ﬂuorescence, TEM and dy-
namic light scattering (DLS).
To evaluate the controlled drug delivery properties of
copolymer aggregates, chlorambucil, an anticancer drug
was used as a model because of its very low solubility in
water. Chlorambucil is a derivative of nitrogen mustard
and acts as a cell cycle phase non-speciﬁc bifunctional
alkylating agent. Alkylation takes place through the forma-
tion of a highly reactive ammonium radical. This radical
likely forms a cross-linkage between two strands of DNA,
interfering with DNA, RNA and protein synthesis. Their pri-
mary uses are chronic lymphocytic leukemia, Hodgkin’s
lymphoma, Non-Hodgkin’s lymphoma and also is used in
ovarian cancer. Enhancement of therapeutic efﬁciency of
highly hydrophobic drugs may be achieved by improving
their solubility. Moreover, chlorambucil exhibits ﬂuores-
cence emission which allows monitoring drug release by
ﬂuorescence measurements.
2. Experimental section
2.1. Materials
Poly(caprolactone) diol (Aldrich, Mn  2000 g/mol), 2-
bromoisobutyryl bromide (Aldrich, 98%), triethylamine
(TEA, Fischer, 99%, stored over potassium hydroxide pel-
lets), iodomethane (Aldrich, 99%) were used as received
without further puriﬁcation. 2-(dimethylamino)ethyl
methacrylate (DMAEMA, Aldrich, 99%) was puriﬁed by pas-
sage through a short column of activated basic alumina be-
fore use to remove inhibitors and acidic impurities. Copper
bromide (Cu(I)Br) (Aldrich, 99%) was puriﬁed according to
the method of Keller and Wycoff [18]. N-(Propyl)-2-pyr-
idylmethanimine was prepared as described earlier [19].
Toluene (BDH, 98%) was degassed by bubbling with nitro-
gen for 30 min and water used in all experiments was Mil-
liQ-grade. Bovine serum albumin (BSA, >95%, Mn  66 kDa,
fraction V) was purchased from Sigma.
2.2. Synthesis of amphiphilic copolymers
ABA triblock copolymers with different lengths of DMA-
EMA were synthesized via a two-step reaction (Fig. 1).2
Firstly, a dihydroxy PCL was end-functionalized using 2-
bromoisobutyryl bromide. The resulting polymer was used
as macroinitiator in the polymerization of DMAEMA lead-
ing to triblock copolymers with a central core of PCL and
PDMAEMA as terminal blocks of different lengths. A simi-
lar experimental procedure was recently reported [20].
2.2.1. Synthesis of macroinitiator
2-Bromoisobutyryl bromide (9.3 mL, 75 mmol) and tri-
ethylamine (10.5 mL, 75 mmol) were added to an anhy-
drous THF solution (300 mL) of a, x-hydroxy terminated
poly-e-caprolactone (Mn = 2000 g/mol) under a nitrogen
atmosphere. The reaction was carried out at ambient tem-
perature overnight. The precipitated salts were removed
via ﬁltration and volatiles removed under reduced pres-
sure. The obtained viscous oil product was dissolved in
dichloromethane and washed with saturated NaHCO3
solution. The organic phase was dried over anhydrous
magnesium sulphate and removed. The solid and white
product was eluted through a basic alumina column with
dichloromethane (yield = 70%).
2.2.2. Synthesis of triblock copolymers
Three block copolymers were synthesized by changing
the feed composition. The ratio between the concentra-
tions of initiator, catalyst and ligand were maintained con-
stant in all the polymerizations ([I]:[C]:[L] = 1:2:4.2). The
ratios of monomer concentration to initiator were 70:1
for PDMAEMAco(30); 60:1 for PDMAEMAco(25) and 50:1
for PDMAEMAco(20).NEt
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Fig. 1. Scheme of synthesis of the triblock copolymers based on 2-A typical polymerization procedure is detailed below.
PCL based macroinitiator (2 g, 0.88 mmol) was placed
in a Schlenk tube and dissolved in deoxygenated
toluene (24 mL). 2-(N,N-dimethylamino)ethyl methacry-
late (10.4 mL, 61.6 mmol) was added to the solution. Then,
the tube was sealed with a rubber septum and the mixture
degassed via three freeze-pump-thaw cycles. Cu(I)Br
(0.25 g, 1.76 mmol) was added to the frozen mixture and
it was deoxygenated by three vacuum-N2 cycles. The reac-
tion mixture, under an atmosphere of nitrogen, was placed
in an oil bath at 80 C. Once the solution reached the de-
sired reaction temperature of 80 C, N-propyl-2-pyridi-
nylmethyleneamine (0.59 mL, 3.69 mmol) (t = 0) was
added. The reaction mixture immediately turned dark
brown in colour in addition of the ligand. Samples were re-
moved periodically throughout the reaction in order to fol-
low the polymerization by 1H NMR in CDCl3 and GPC.
Polymerization was ﬁnished after 4 h by exposing the reac-
tion solution to air, leading to aerial oxidation of the cata-
lyst. Catalyst residues were removed by ﬁltering through
an activated basic alumina column. The volatiles were re-
moved by rotary evaporation and under high vacuum at
ambient temperature.
2.2.2.1. 1H NMR (CDCl3, 400 MHz). d (ppm): 0.90 (3H, m,
CH3–CPDMAEMA), 1.40 [28H,m, 14OC–(CH2)3–CH2–CH2OPCL],
1.65 [56H, m, 14OC–CH2–(CH2)2-(CH2)2–OPCL], 1.85 (12H, s,
4CH3PCL), 1.95 (2H, m, Br–CH2–C–PDMAEMA), 2.30 [28H, m,
14OC–CH2–(CH2)4–O–PCL], 2.30 [6H,m, –N–(CH3)2PDMAEMA],
2.55 (2H, m, –CH2–NPDMAEMA), 3.65 [4H, m, 2O–CH2–CH2–3
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OCOPCL], 4.05 [24H,m, 12OC–(CH2)4–CH2OPCL], 4.05 (2H,m,
–COO–CH2–PDMAEMA), 4.20 [4H, t, 2O–CH2–CH2–OCOPCL],
4.35 [4H, m, 2OC–(CH2)4–CH2,OCOPCL].
2.2.2.2. IR (KBr). m (cm1): 2950 (st, C–H), 2824 (st, O–CH2),
2772 [N–(CH2)2–ODMAEMA], 1730 (O–C@ODMAEMA), 1460,
1274 (PDMAEMA), 1154 (H2C–O–CH2), 750 [c, C–(CH2)n–
CPCL].
2.2.3. General procedure for quaternization of PDMAEMA
triblock copolymers with MeI
Polymer (1 g) was dissolved in dichloromethane
(50 mL) at 25 C under an atmosphere of nitrogen.
Methyl iodide (1.71 g, 12 mmol) was added and the mix-
ture was stirred vigorously at 25 C for 24 h. Precipita-
tion of the polymer starts to occur after 20–30 min.
The reaction mixture was ﬁltered and the quaternized
PDMAEMAcoQ(x) polymer was dried under vacuum.
2.2.4. General procedure for quaternization of PDMAEMA
triblock copolymers with HCl
Polymer (2.9 g) was dissolved in 100 mL of water and
40 mL of 0.5 M HCl (aq) with stirring. The solution was fro-
zen in liquid nitrogen and lyophilized to give the corre-
sponding chlorohydrated PDMAEMAcoCl(x) copolymers.
2.3. Optical transmittance measurements
Optical transmittance of PDMAEMA block copolymer
(1.5 g/L) in phosphate buffer solution (PBS, 0.01 M, pH
7.4 and pH 6.4) at various temperatures was measured
at 550 nm with a Lambda 32 UV–vis spectrometer (Per-
kin-Elmer). The sample cell was thermostated in a
refrigerated circulator bath at different temperature from
10 to 90 C prior to measurements. The LCST of the
polymer solution was deﬁned as the temperature pro-
ducing a half decrease of the total decrease in optical
transmittance.
2.4. Fluorescence measurements
The cmc’s were determined by a ﬂuorescence probe
technique using 4-( N,N-diethyl) amino-7-nitrobenz-2-
oxa-1,3-diazole (NBD-NEt2) as a ﬂuorescent probe, syn-
thesized as previously described [21]. Fluorescence
emission spectra were recorded on a Perkin-Elmer
LS-50B spectroﬂuorimeter. All measurements were per-
formed at 20 ± 1 C. To improve the accuracy in the deter-
mination of maximum wavelengths ﬁrst derivative
spectra were obtained in all of the wide emission bands.
Sample solutions were prepared by dissolving a known
amount of polymer in water, from 2  103 to 20 g/L. As
the employed ﬂuorescent probe exhibits low solubility
in water, stock solutions were prepared in ethanol. The
stock solution (2.2  103 M) was added into the exam-
ined polymer water solutions of a given concentration
in amounts less than 1.5 vol.%, and the solutions were al-
lowed to stand 1 day for equilibration. The effective con-
centration of probe was maintained at 4  106 M in all
the aqueous solutions. Fluorescence emission spectra of
the probe were recorded in the range 490–700 nm usinga ﬁxed excitation wavelength of 477 nm. Under such
experimental conditions, only one single ﬂuorescence
emission peak was observed. All the spectra were cor-
rected using the response curve of the photomultiplier.
2.5. Dynamic light scattering (DLS)
Solutions for light scattering measurements were pre-
pared by dissolving the triblock copolymer in previously
ﬁltered, distilled deionized water. DLS measurements were
performed using a Malvern Zetasizer 3000 spectrometer
equipped with a 5 mW helium neon laser operating at
633 nm. All measurements were carried out with 5 g/L
copolymer solution at a scattering angle of 90 and at
ambient temperature. The aggregates sizes were deter-
mined with the data ﬁtted with CONTIN algorithm as sup-
plied by Malvern Instruments.
2.6. Transmission electron microscopy (TEM) measurements
TEM images were obtained using an electron micro-
scope Philips Tecnai 20T operating at 200 kV. To prepare
the TEM samples, 5 microL of an aqueous solution of block
copolymer micelles was dropped onto a carbon-coated
copper grid and the water droplet was allowed to evapo-
rate slowly in air.
2.7. Drug loading
The triblock copolymers (60 mg, 1% w/v) were dis-
solved in 6 mL of a phosphate buffer solution (PBS,
0.01 M, pH 7.4). Solution was stirred in the dark over-
night. Chlorambucil was dissolved in ethanol. Speciﬁc
volumes of the drug and copolymer stock solutions were
mixed to achieve a ﬁnal copolymer concentration higher
than cmc and drug to polymer ratio of 1:5 (w/w). Drug
concentration was varied from 1 to 160 lM. The copoly-
mer-drug solutions were stirred for 4 h, and then placed
in a dialysis cell (molecular weight cut-off: 1000 g/mol,
Spectrapore). Excess of drug was removed by dialysis
against PBS solution (0.01 M, pH 7.4) during 24 h. To
determine the entrapment efﬁciency, the drug loaded
micelles solution was lyophilized and then, dissolved in
ethanol. The loaded aggregates were disrupted by the
addition of ethanol (micellar solution: ethanol ratio,
1:2500, v/v).
The loading efﬁciency of chlorambucil incorporated
into the triblock copolymer micellar aggregates was
determined by ﬂuorescence. The ﬂuorescence assay in-
cluded measurement of the emission intensity at 348
and 338 nm with an excitation wavelength of 305 nm.
By plotting emission intensity at 348 nm as a function
of concentration a standard curve for chlorambucil in
PBS solution was prepared over the concentration range
of 5  102–6  103 g/L. A second standard curve was
obtained over the concentration range 5  103–106 g/
L, using the emission intensity at 338 nm. Both curves
showed correlation coefﬁcients higher than 0.995. The
drug loading content (DLC), and the drug loading efﬁ-
ciency (DLE) were calculated from the following
equations:4
Drug loading content ð%Þ¼Weight of loaded drug inmicellesðgÞ
Weight of drug loadedmicellesðgÞ 100
Efficiency ð%Þ¼Weight of loadeddrug inmicellesðgÞ
Weight of drug addedðgÞ 1002.8. In vitro drug release
A dialysis bag (MWCO = 1000 Da) containing 6 mL of
the drug loaded micelle suspension was sealed and im-
mersed in a phosphate buffer solution (250 mL, 0.01 M,
pH 7.4) at 37 C in a thermostatically controlled bath. The
copolymer concentration was 1% wt for PDMAEMAcoCl(30)
and (20) and 3.3% wt for PDMAEMAcoCl(25). The ratio
drug: copolymer was 1:5 (wt/wt) in all the experiments.
After 24 h of dialysis, the dialysis cell was maintained into
a freshly prepared 0.01 M PBS solution. Aliquots of 5 mL
were withdrawn from the solution periodically. The vol-
ume of the solution was held constant by adding 5 mL
fresh PBS solution after each sampling to ensure sink con-
ditions. The amount of chlorambucil released from mi-
celles was determined by ﬂuorescence at 305 nm as
excitation wavelength.
2.9. Measurements
1H NMR and 13C NMR spectra were recorded in D2O
solution on a Bruker AM-400 instrument at 400 MHz.
IR spectra were recorded on a Perkin-Elmer FTIR-spectro-
photometer and polymeric samples were examined as
KBr discs. Elemental analysis: nitrogen and sulphur con-
tents were determined by elemental analysis in a Micro-
Carlo Erba equipment, model EA 1108. GPC molecular
weights and polydispersity measurements were carried
out using a Polymer Laboratories GPC system equipped
with a differential refractive index and UV–vis detectors.
Calibration was carried out using linear poly(methyl
methacrylate) (PMMA) standards (Polymer Laboratories),
ranging from 200 to 1.577  105 g mol1. The mobile
phase was THF/triethylamine (5% v/v) at a ﬂow rate of
1 mL min1. Triethylamine was added to circumvent
adsorption of polyamine on the SEC columns. The system
was equipped with a guard column PL-gel 5 lm and two
C PL-gel 5 lm mixed columns in series, thermostated at
25 C.3. Results and discussion
3.1. Synthesis of the copolymers
ABA block copolymers were synthesized from difunc-
tional macroinitiator PCL using copper-mediated living
radical polymerization (LRP). Polymerization of (2-(N,N-
dimethylamino)ethyl methacrylate was carried out at
80 C in toluene using N-propyl-2-pyridinylmethylene-
amine as a ligand [22] and Cu(I)Br. Table 1 summarizes
feed composition (fDMAEMA: molar fraction of DMAEMA in
the feed), together withMn and composition of copolymers
(FDMAEMA: molar fraction of DMAEMA in the copolymer)determined by GPC and by elemental analysis, respec-
tively. The data conﬁrm the absence of diblock copolymers.
The copolymers were named as PDMAEMAco(x), where x
denoted the polymerization degree of each DMAEMA
block.
Each polymerization was sampled with time and ana-
lyzed by 1H NMR and GPC for measurement of conversion,
molecular weight and polydispersity. Calculations were
performed by 1H NMR with comparison of the relative
integration of the signals at 5.0 and 5.6 ppm assigned to
the protons of monomeric double bond and that at
3.5 ppm for methylene protons of PDMAEMA. The kinetic
plots, ln [M]/[M0] versus time, for the polymerization of
DMAEMA using different composition feeds are shown in
Fig. 2 with linear plots indicating good ﬁrst order kinetics
and the concentration of growing radicals was constant
during the reaction. All the polymers showed a relatively
narrow molecular weight distribution and polydispersity
1.2. These results suggest a controlled/living radical
mechanism under these conditions.
Selective quaternization of PDMAEMA blocks was car-
ried out by reaction with HCl to give rise to water-soluble
PDMAEMAcoCl copolymers. Also water-soluble PDMA-
EMAcoQ copolymers were obtained by reaction with
methyl iodide. The polyelectrolytes were characterized by
FTIR and 1H NMR. In the FTIR spectrum, absorption at
2700 cm1 from the ammonium group conﬁrmed the
structure of polyelectrolytes.
3.2. Polymeric micelles
The structures of the triblock copolymers were charac-
terized by 1H NMR. Assignments of methylene protons
(1.2–1.6 and 2.2 ppm) for the PCL block and methyl pro-
tons (2.3 ppm) and methylene protons (2.5 ppm) for the
PDMAEMA blocks are shown in Fig. 3, which showed suc-
cessful formation of the triblock copolymer. In CDCl3,
where micellar formation was not expected, all 1H NMR
resonances attributed to PDMAEMA and PCL units were
detected as shown in Fig. 3a. However, the 1H NMR spec-
trum in D2O showed an intensity reduction of PCL reso-
nances due to suppressed molecular motion of the
aggregated hydrophobic chains (Fig. 3b). 1H NMR study
in aqueous solution showed mainly hydrophilic PDMAEMA
signals, strongly indicative of a core–shell type formation
with a hydrophobic inner-core and a hydrophilic shell.
The formation of micelles from the triblock copolymers
was also veriﬁed by and DLS measurements and ﬂuores-
cence, using 4-(N,N0-diethyl)amino-7-nitrobenz-2-oxa-
1,3-diazole (NBD-NEt2) as ﬂuorescent probe. At low
concentrations, copolymer exists as unimers; self-assem-
bly begins when the copolymer concentration reached
the called cmc. The cmc of chlorohydrated and quaternized
copolymers were determined by the ﬂuorescence method
described previously [23]. Fig. 4 shows the plots of the ra-
tio of ﬂuorescence quantum yields in presence and ab-
sence of copolymer versus copolymer concentration.
From this plot was possible to determine the onset of
microdomain formation put in evidence by the drastic
slope change corresponding to the value of cmc (Table 2).
At ambient temperature, the range of cmc’s for5
Table 1
Polymerization of DMAEMA using a difunctional macroinitiator based on PCL at 80 C in toluene
Copolymers fDMAEMAa FDMAEMAb Mn,thc (g/mol) Mn,GPCd (g/mol) PD PId Conversion (%)
PDMAEMACo(30) 0.90 0.96 11100 11700 30 1.22 80
PDMAEMACo(25) 0.80 0.77 9800 10500 25 1.22 80
PDMAEMACo(20) 0.70 0.74 8780 9800 20 1.20 82
Polymerization degree (PD) of each DMAEMA block, molecular weight and molecular weight distribution of the triblock copolymers.
a Molar fraction of DMAEMA in the feed.
b Molar fraction of DMAEMA in the copolymer.
c Mn;th ¼ ðð½Monomer0 Mw;monomer  ConversionÞ=½Macroinitiator0Þ þMn;macroinitiator.
d Determined by GPC, standards PMMA.
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Fig. 3. 1H NMR of the triblock copolymer PDMcule. As the length of the hydrophilic block PDMAEMA in-
creases the cmc decreases.
In general, the cmc for PDMAEMAcoCl are lower than
those for PDMAEMAcoQ and the opposite trend is observed
for the ratio of UF/UF0. This behaviour may be related to a
looser polymeric micelles with a higher aggregation num-
ber for PDMAEMAcoQ as a result of the higher size of the
iodide anion compared with the chloride ion in PDMA-
EMAcoCl. However, the values of cmc of PDMAEMAcoCl(20)
and PDMAEMAcoQ(20) were very close. Both copolymers
exhibited a drastic increase of the ﬂuorescence quantum
yield at concentrations higher than the cmc, independently
of the counter-ion of the ammonium group of PDMAEMA
blocks. This pattern suggested that the repulsive interac-
tions between hydrophilic segments are not affected by
the counter-ion due to the shortest length of these blocks.
We also evaluated the mobility/rigidity of the poly-
meric micelles by using the ﬂuorescent probe, NBD-NEt2,
which has been proven to be sensitive to mobility/rigidity
changes in its microenvironment [24]. Fluorescence inten-
sity increases due to the increasing viscosity surrounding
the probe. This behaviour has been interpreted by assum-
ing that the intramolecular charge transfer (ICT) excitedppm2.8 2.6 2.4 2.2 2.0 1.8 1.6 1.4 1.2 1.0 0.8
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Fig. 4. Plots of the ratio uF/uF0 against copolymer concentration for PDMAEMACoCl copolymers (solid symbols) and PDMAEMACoQ copolymers (open
symbols). The structure of the ﬂuorescent probe NBD-NEt2 is showed as an inset in the ﬁgure.
Table 2
Critical micellar concentrations (cmc in g/L) of PDMAEMAcoCl and PDMA-
EMAcoQ triblock copolymers in the absence and presence of bovine serum
albumin (BSA)
Copolymer PDMAEMAcoCl PDMAEMAcoCl in
presence of BSAa
PDMAEMAcoQ
PDMAEMACo(30) 0.11 0.03 0.31
PDMAEMACo(25) 0.33 0.05 0.71
PDMAEMACo(20) 1.01 0.20 1.10
a [BSA] = 0.2 g/L.state relaxes to a lower energy twisted intramolecular
charge transfer (TICT) state by rotation about the amino
group carbon–nitrogen bond. The radiative deactivation
constant is not affected, but a decrease in the non-radiative
deactivation constant is related to an increase in the vis-
cosity [21]. Therefore, when the inner-core rigidity in-
creases the slope of the plot of the ratio of ﬂuorescence
quantum yields versus copolymer concentration increases.
At concentrations much greater than the cmc, the steepest
slope was shown by the formation of PDMAEMAco(20) mi-
celles, indicating a tightly hydrophobic PCL core whereas
the lowest slope corresponded to the formation of PDMA-
EMAco(25) loose micelles.
It can not be excluded changes in the partition coefﬁ-
cient of the ﬂuorescent probe depending on the copolymer.
However, we were not succeeded to determine partition
coefﬁcient with this ﬂuorescent probe in these systems.
This fact was due to a continuous increase of ﬂuorescence
as the concentration of copolymer is increased up to
100 mg/mL and ﬂuorescence intensity does not level-off.
Therefore, the saturation intensity (the intensity for the
probe does not change with increasing polymer concentra-
tion) was not reached for the range of copolymer concen-
tration used in this work.
PDMAEMAcoCl block copolymers and proteins share a
common property of both charged groups and hydrophobic
regions. This implies that the solution properties might bevery different than those of individual solutions. The mic-
ellization onset of PDMAEMAcoCl in presence of a protein,
bovine serum albumin (BSA), was studied and data are
compiled in Table 2. The plot of the ratio of UF/UF0 versus
copolymer concentration deﬁned a clear breakpoint when
a certain copolymer concentration was reached. The begin-
ning of the interaction between copolymer and protein
was typically displayed as critical aggregation concentra-
tion (cac) which lay below the cmc of the respective
copolymers. At neutral pH BSA is negatively charged and
copolymers are cationic. Therefore, cooperative binding
of molecules can be induced hydrophobically and/or elec-
trostatically. It is suggested that the surfactant molecules
in our present studies bind to form the micelle-like clusters
in the protein–surfactant complex.
The micelles formed of PDMAEMAcoCl copolymers were
studied by dynamic light scattering in order to measure
their effective diameter and their population distribution
in terms of size. Fig. 5 shows the population distribution
of the micelles calculated by CONTIN analysis of the dy-
namic light scattering measurements. The micelles exhib-
ited a distinct size distribution pattern depending on
their composition. In PDMAEMACoCl(25) copolymer, a bi-
modal size distribution was observed, most of the popula-
tion had a mean diameter of about 150 nm, and the
remaining population exhibited smaller size of about
30 nm. Bimodal distributions have been obtained for other
polymer micelles such as amphiphilic di and triblock
copolymers of styrene and quaternized 5-(N,N-diethyl-
amino) isoprene in selective solvents [25]. The largest size
aggregates were observed for PDMAEMACoCl(30) copoly-
mer with more complex size distribution. An opposite
trend was observed for PDMAEMACoCl(20) showing a nar-
row and monodispersed size distribution.
Generally, the size of core–shell type polymeric micelles
lies in the range of several tens of nanometers. Therefore,
the larger size fraction of population corresponds to
supramolecular structures formed by an intermolecular7
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Fig. 5. Population distribution of the micelles calculated by CONTIN
analysis of the dynamic light scattering measurements.
Fig. 6. TEM images of the resulting micelles self-assembled of PDMA-
EMACoCl(25) in aqueous media.
Table 3
Hydrodynamic diameter of copolymer micelles determined by dynamic
light scattering (Dh) and theoretical hydrodynamic diameter calculated
assuming a spherical morphology of micelles
Copolymer Dh (nm) Dh th (nm)
PDMAEMACoCl(30) 30 ± 6 24
PDMAEMACoCl(25) 28 ± 6 21
PDMAEMACoCl(20) 17 ± 4 18aggregation process. Particles exceeding 100 nm are aggre-
gates that result from intermicelle association and hydro-
phobic interactions between the exposed cores of
micelles [26]. We believe that secondary aggregation
might be strongly favoured when PDMAEMA is used as
the peripheral block because of its amphiphilic nature.
The extension of the ionic block played a key role in tuning
the size of micelles. As polymerization degree of PDMA-
EMA block increased the systems attempted to decrease
the total interfacial area, and micelles fusion occurred,
resulting in an increase in the micelles size and a decrease
of the total number of particles. The aggregates showed a
spherical morphology (Fig. 6a) and a close inspection of
the TEM micrograph showed secondary aggregation as
well (Fig. 6b). Hence, the maximum value of the theoretical
micellar diameter (Dh th) was calculated as the sum of the
length of the PCL central block and twice the length of the
peripheral block. The length of each block was determined
by the product of polymerization degree multiplied by the
polydispersity degree and by the contribution of a mono-
meric repetition unit to the chain length (0.2546 nm). For
all the copolymers, the value of the mean diameter corre-
sponding to the smallest aggregates is closed to that esti-
mated from a spherical model micelle (Table 3).
3.3. Thermoresponsive behaviour
To determine whether these micelles exhibit a thermal
sensitivity as expected [27], we further examined the opti-
cal transmittance of a polymeric micelle PBS solution (pH
7.4) as a function of temperature. Concentration of poly-
meric solutions (1.5 g/L) was chosen well-above cmc of
all the copolymers to ascertain the formation of polymeric
micelles. Whilst the PCL block is hydrophobic, the PDMA-
EMA blocks are hydrophilic at ambient temperature andbecome hydrophobic above the demixing temperature as
a result of the lower critical solution temperature (LCST)
behaviour. The %T changes as a function of temperature
of PDMAEMAcoCl aqueous solutions measured at 550 nm,
Fig. 7. PDMAEMAcoCl block copolymers are thermal-sensi-
tive polymers exhibiting LCST. These micelles underwent a
change in their structure at different temperatures, be-
tween 54 and 87 C, depending on their composition. And
PDMAEMACoCl(25) exhibited the lowest LCST (54 C) in
accordance with the lowest rigidity of these micelles.
Moreover, the soluble–insoluble change was entirely
reversible without hysteresis for PDMAEMACoCl(30) as8
demonstrated by the transition from a turbid solution to a
transparent solution when the aqueous temperature was
decreased from above to below the LCST. However, the
thermoresponsive behaviour was found reversible with a
slower response rate as the length of hydrophilic block de-
creased for the other triblock copolymers. We suggest that
the coronas of the micelles were crowded in a way that
could hinder the relaxation of PDMAEMA blocks. Similar
behaviour was observed for poly(styrene-b-N-isopropylac-
rylamide) [28]. The inﬂuence of macromolecular architec-
ture on the thermal response rate of amphiphilic
copolymers based on poly(N-isopropylacrylamide) and
poly(oxyethylene) in water has been recently studied
[29]. These authors found that the thermal response of
graft copolymers is faster than that of block copolymers.
3.4. Drug loading efﬁciency
Dialysis is an effective method for drug loading into mi-
celles and for assessing the in vitro drug release. Chloram-
bucil was solved in ethanol and added to the copolymer
solution; followed by dialysis of this solution against phos-
phate buffer solution. A gradual replacement of the organic
solvent with water triggered self-assembly of hydrophobic
PCL blocks accompanied by the entrapment of drug in mi-
celles cores. The drug loading efﬁciency, cmc and a factor F
deﬁned by the ratio between the initial copolymer concen-
tration and its cmc are listed in Table 4.
The drug loading efﬁciency (DLE) varied between 30%
and 78%. By increasing weight ratio of drug to polymer in-
creased DLE. For example, in the case of PDMA-
EMACoCl(25), the feed weight ratio of chlorambucil to
polymer increased from 0.2 to 0.66, the DLE increased from
39% to 78%. Also, the drug loading efﬁciencies depended on
composition of block copolymer. For PDMAEMA copoly-
mers, PDMAEMACoCl(25) has the highest DLE while PDMA-
EMACoCl(30) shows the lowest DLE. It is well-known that
the interactions between the drug and the core block
determine the encapsulation of the drug [30]. Chlorambu-
cil is inherently hydrophobic due to its chemical structure
and possess a carboxylic acid group. The presence of water
inside the hydrophobic core may be very low, avoiding the20 30 40 50 60 70 80 90
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Fig. 7. Thermoresponsive behaviour of self-assembled micelles upon
temperature changes.hydration of carboxylic acid groups of drug and resulting in
the hydrogen bond formation between the carbonyl moie-
ties of PCL and the acid group of chlorambucil, Fig. 8. The
speciﬁc interaction is expected to work preferentially for
drug incorporation without producing precipitates which
can be frequently seen in cases of non-speciﬁc hydropho-
bic interactions. Therefore, physical entrapment of hydro-
phobic drugs into micelles is believed to be driven by
hydrophobic interactions and hydrogen bonds between
drug and hydrophobic core. Moreover, this interaction be-
tween drug-polymeric micelles may inﬂuence on the drug
release behaviour.
The nature of the shell was found to play a key role in
self-assembly behaviour and DLE decreased considerably
for PDMAEMACoQ(25) compared to the counterpart PDMA-
EMACoCl(25) (Table 3). Taking into account that the length
of the hydrophobic block based on PCL was maintained
constant in all the copolymers, the expansion of micelle
shell may cause hindrance to drug encapsulation resulting
in lower DLE.
3.5. In vitro chlorambucil release studies
The time-dependent drug release proﬁle of the micelles
in 0.01 M PBS aqueous solution at 37 ± 1 C was studied,
Fig. 9. Interestingly, the PDMAEMACoCl(20) micelles re-
leased chlorambucil in a sustained manner over more than
100 h. In contrast, a relatively rapid release was observed
within the ﬁrst 24 h, followed by slow, sustained release
over a 4-day period, from PDMAEMACoCl(30) micelles.
The release rates were very different, even if the initial
drug loading was the same. In fact, during the ﬁrst 24 h
of exposure, the PDMAEMACoCl(30) micelles showed a
70% of released drug, compared with a 22% released from
the PDMAEMACoCl(20) micelles Surprisingly, the release
behaviour from PDMAEMACoCl(25) followed an acceler-
ated process after a short induction period. This pattern
is explained by the formation of aggregates with different
sizes, as conﬁrmed by DLS. In comparison to the release
behaviour from a monodispersed sample, the presence of
a particle size distribution causes a substantial acceleration
of the transport at early times [31].
In order to investigate the mechanism of drug release
and to compare the performance of various copolymers
micelles, the percentage of drug released versus time pro-
ﬁles were used. Data corresponding to 5–60% release
showed a good ﬁt to the Power Law Model [32] expressed
in the following equation:
Mt
M1
¼ k  tnTable 4
Drug loading content and efﬁciency (DLC and DLE), cmc and a factor F
(F = [copolymer]0/CMC) of the PDMAEMAco micelles
Copolymer cmc (g/L) Factor DLC (%) DLE (%)
PDMAEMACoCl(30) 0.11 100 4.8 29
PDMAEMACoCl(25) 0.33 30 6.6 39
100 13.0 78
PDMAEMACoCl(20) 1.01 10 5.6 34
PDMAEMACoQ(25) 0.71 14 0.5 3
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Fig. 9. Drug release proﬁles from micelles formed by triblock copolymers
PDMAEMACoCl containing chlorambucil.where Mt was the amount of drug released at time t, M1
was the amount of drug released after inﬁnite time, k
was a kinetic constant incorporating structural and geo-
metric characteristics of the system, and n was the diffu-
sional exponent indicative of the drug release
mechanism. For spherical geometry, values of n value be-
tween 0.43 and 0.85 can be regarded as an indicator for
the superposition of two phenomena (diffusion-controlled
and swelling-controlled drug release) [31]. The values of
the kinetic constant (k), the release exponent (n) and corre-
lation coefﬁcient (R2) were determined according to this
equation from the drug release proﬁles. The correlation
coefﬁcients for the data were >0.99 and illustrated thatthe release were predictive by the empirical exponential
equation. Values of n equals to 0.73 for PDMAEMACoCl(20)
and 0.5 for PDMAEMACoCl(30) indicated anomalous trans-
port and the release was controlled by a combined degra-
dation–diffusion mechanism in all cases. The degradation
or erosion can be caused by deagglomeration and/or chem-
ical hydrolysis of PCL core. Taking into account the suspen-
sions showed secondary aggregation (TEM images), the
surface area of the system is also responsible for the differ-
ent burst release and the mechanism could be related to
both particle deagglomeration and drug diffusion.
Homopolymer PCL is a highly hydrophobic material
with a slow in vitro hydrolytic degradation rate. After
attaching hydrophilic DMAEMA blocks at both extremes
of the linear PCL, the resultant copolymers became more
hydrophilic compared with PCL. The hydrolytic stability
of the polymeric micelles was dependent on the length of
the hydrophilic blocks. This behaviour and biodegradabil-
ity is currently under investigation. We have observed that
different genera of bacteria, such as Pseudomonas and
Bacillus, grew in aqueous solutions in the presence of these
amphiphilic copolymers. Surprisingly they are biodegrad-
ed below cmc and also, above cmc.
4. Conclusions
A series of novel amphiphilic triblock copolymers based
on 2-(N,N-dimethylamino)ethyl methacrylate and e-capro-
lactone were designed and synthesized. Thermosensitive
triblock copolymers self-assembled into supramolecular
aggregates in aqueous solution and exhibited cmc’s rang-10
ing from 0.11 to 1.01 g/L. In presence of proteins, PDMA-
EMA block copolymers formed micelle-like clusters by
cooperative binding. Investigation of polymeric micelles
in aqueous medium showed that the composition of the
hydrophilic segment has a signiﬁcant inﬂuence on its
physicochemical characteristics. These polymeric micelles
were loaded with an anticancer drug, chlorambucil. The
drug loading efﬁciency of PDMAEMA micelles was opti-
mized by entrapping the poorly water-soluble drug con-
taining functional groups capable to interact by hydrogen
bonds with the PCL core-forming block. Comparing to
other PCL copolymers, the PDMAEMA copolymers exhib-
ited smaller cmc’s and better drug loading properties.
The role of secondary aggregation in the drug incorpora-
tion was put in evidence.
The control of the drug release kinetics can be achieved
by optimizing the composition of the used polymers and
the particle size of the nanoparticles. For example, PDMA-
EMACoCl(20) micelles could prove useful for drug delivery
applications as a very sustained release from a very small
drug reservoir is required for its drug targeting, which indi-
cated that the nanoparticles were very suitable for delivery
carriers of hydrophobic probes.
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